NO20010468L - Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi - Google Patents

Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi

Info

Publication number: NO20010468L
Authority: NO; Norway
Prior art keywords: replacement therapy; hormone replacement; biogenic estrogen; estrogen sulfamates; sulfamates
Prior art date: 1998-07-28

Application number

NO20010468A

Other languages

English (en)

Norwegian (no)

Other versions

NO20010468D0 (no

Inventor

Walter Elger

Pekka Lohteenmoki

Matti Lehtinen

Gudrun Reddersen

Holger Zimmermann

Michael Oettel

Sigfrid Schwarz

Original Assignee

Jenapharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-28

Filing date

2001-01-26

Publication date

2001-03-27

2001-01-26 Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh

2001-01-26 Publication of NO20010468D0 publication Critical patent/NO20010468D0/no

2001-03-27 Publication of NO20010468L publication Critical patent/NO20010468L/no

Links

230000000035 biogenic effect Effects 0.000 title 1
229940011871 estrogen Drugs 0.000 title 1
239000000262 estrogen Substances 0.000 title 1
238000002657 hormone replacement therapy Methods 0.000 title 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

NO20010468A 1998-07-28 2001-01-26 Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi NO20010468L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19834931A DE19834931A1 (de)	1998-07-28	1998-07-28	Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
PCT/DE1999/001496 WO2000006175A1 (de)	1998-07-28	1999-05-13	Verwendung von biogenen estrogenssulfamaten zur hormonsubstitutionstherapie

Publications (2)

Publication Number	Publication Date
NO20010468D0 NO20010468D0 (no)	2001-01-26
NO20010468L true NO20010468L (no)	2001-03-27

Family

ID=7876248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010468A NO20010468L (no)	1998-07-28	2001-01-26	Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi

Country Status (28)

Country	Link
US (1)	US7053077B1 (is)
EP (1)	EP1100509B1 (is)
JP (1)	JP4891479B2 (is)
KR (1)	KR20010072082A (is)
CN (1)	CN1311683A (is)
AP (1)	AP2001002054A0 (is)
AR (1)	AR016502A1 (is)
AT (1)	ATE292468T1 (is)
AU (1)	AU766019B2 (is)
BG (1)	BG105171A (is)
BR (1)	BR9912466A (is)
CA (1)	CA2338558A1 (is)
CO (1)	CO5261567A1 (is)
DE (2)	DE19834931A1 (is)
EA (1)	EA003371B1 (is)
EE (1)	EE200100053A (is)
HK (1)	HK1040192A1 (is)
HU (1)	HUP0102913A3 (is)
IL (1)	IL141081A0 (is)
IS (1)	IS5819A (is)
MX (1)	MXPA01000548A (is)
NO (1)	NO20010468L (is)
NZ (1)	NZ509521A (is)
PL (1)	PL345588A1 (is)
SK (1)	SK1292001A3 (is)
TR (1)	TR200100234T2 (is)
WO (1)	WO2000006175A1 (is)
ZA (1)	ZA200100743B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1406634A1 (en) *	2001-07-13	2004-04-14	Schering Aktiengesellschaft	Combination of drospirenone and an estrogen sulphamate for hrt
US8026229B2 (en)	2001-08-13	2011-09-27	Sterix Limited	Antitumor-active 2-alkoxyestradiol sulfamates
US8282612B1 (en)	2008-03-07	2012-10-09	Denise H. Miller	Methods and devices for intrauterine absorption
RS62297B1 (sr)	2011-11-23	2021-09-30	Therapeuticsmd Inc	Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
EP2647379A1 (en) *	2012-04-05	2013-10-09	PregLem S.A.	Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US9078786B1 (en)	2012-10-19	2015-07-14	Denise H. Miller	Methods and devices for collecting body fluids
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru)	2014-05-22	2018-06-26	Терапьютиксмд, Инк.	Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US9931349B2 (en)	2016-04-01	2018-04-03	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
CN116392450B (zh) *	2022-09-07	2025-07-01	江苏集萃新型药物制剂技术研究所有限公司	含雌激素的皮下植入物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5314694A (en) *	1990-10-29	1994-05-24	Alza Corporation	Transdermal formulations, methods and devices
AU7075594A (en) *	1993-06-29	1995-01-24	Leiras Oy	Pack for use in, and method of hormonal replacement therapy
DE4429397C2 (de) *	1994-08-09	2003-11-20	Jenapharm Gmbh	Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) *	1994-08-09	1997-09-11	Jenapharm Gmbh	Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429374C1 (de)	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19610635A1 (de) *	1996-03-11	1997-09-18	Schering Ag	Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
TW448049B (en) *	1997-03-05	2001-08-01	Akzo Nobel Nv	Use of a 7Α-methyl-17Α-ethynyl-estrane derivative for the treatment of atherosclerosis
JP2002520346A (ja) *	1998-07-17	2002-07-09	ファルマシア・アンド・アップジョン・カンパニー	避妊用皮下メドロキシプロゲステロンアセタート

1998
- 1998-07-28 DE DE19834931A patent/DE19834931A1/de not_active Withdrawn
1999
- 1999-05-13 EP EP99936276A patent/EP1100509B1/de not_active Expired - Lifetime
- 1999-05-13 CN CN99809213A patent/CN1311683A/zh active Pending
- 1999-05-13 EE EEP200100053A patent/EE200100053A/xx unknown
- 1999-05-13 US US09/744,574 patent/US7053077B1/en not_active Expired - Fee Related
- 1999-05-13 WO PCT/DE1999/001496 patent/WO2000006175A1/de not_active Ceased
- 1999-05-13 AU AU51481/99A patent/AU766019B2/en not_active Ceased
- 1999-05-13 CA CA002338558A patent/CA2338558A1/en not_active Abandoned
- 1999-05-13 IL IL14108199A patent/IL141081A0/xx unknown
- 1999-05-13 NZ NZ509521A patent/NZ509521A/en unknown
- 1999-05-13 HK HK02101596.4A patent/HK1040192A1/zh unknown
- 1999-05-13 KR KR1020017001165A patent/KR20010072082A/ko not_active Withdrawn
- 1999-05-13 AP APAP/P/2001/002054A patent/AP2001002054A0/en unknown
- 1999-05-13 BR BR9912466-1A patent/BR9912466A/pt not_active IP Right Cessation
- 1999-05-13 MX MXPA01000548A patent/MXPA01000548A/es unknown
- 1999-05-13 TR TR2001/00234T patent/TR200100234T2/xx unknown
- 1999-05-13 JP JP2000562029A patent/JP4891479B2/ja not_active Expired - Fee Related
- 1999-05-13 AT AT99936276T patent/ATE292468T1/de not_active IP Right Cessation
- 1999-05-13 HU HU0102913A patent/HUP0102913A3/hu unknown
- 1999-05-13 PL PL99345588A patent/PL345588A1/xx unknown
- 1999-05-13 EA EA200100108A patent/EA003371B1/ru not_active IP Right Cessation
- 1999-05-13 DE DE59911879T patent/DE59911879D1/de not_active Expired - Lifetime
- 1999-05-13 SK SK129-2001A patent/SK1292001A3/sk unknown
- 1999-07-26 CO CO99046902A patent/CO5261567A1/es not_active Application Discontinuation
- 1999-07-27 AR ARP990103678A patent/AR016502A1/es not_active Application Discontinuation
2001
- 2001-01-19 IS IS5819A patent/IS5819A/is unknown
- 2001-01-23 BG BG105171A patent/BG105171A/bg unknown
- 2001-01-25 ZA ZA200100743A patent/ZA200100743B/en unknown
- 2001-01-26 NO NO20010468A patent/NO20010468L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200100743B (en)	2002-05-08
PL345588A1 (en)	2001-12-17
AU5148199A (en)	2000-02-21
NZ509521A (en)	2003-11-28
JP2002521452A (ja)	2002-07-16
WO2000006175A1 (de)	2000-02-10
CA2338558A1 (en)	2000-02-10
JP4891479B2 (ja)	2012-03-07
US7053077B1 (en)	2006-05-30
IS5819A (is)	2001-01-19
BG105171A (bg)	2001-07-31
DE19834931A1 (de)	2000-02-24
NO20010468D0 (no)	2001-01-26
AP2001002054A0 (en)	2001-03-31
KR20010072082A (ko)	2001-07-31
SK1292001A3 (en)	2001-07-10
ATE292468T1 (de)	2005-04-15
CN1311683A (zh)	2001-09-05
AU766019B2 (en)	2003-10-09
EP1100509B1 (de)	2005-04-06
AR016502A1 (es)	2001-07-04
HK1040192A1 (zh)	2002-05-31
HUP0102913A3 (en)	2002-03-28
IL141081A0 (en)	2002-02-10
MXPA01000548A (es)	2002-04-08
EA003371B1 (ru)	2003-04-24
TR200100234T2 (tr)	2001-06-21
BR9912466A (pt)	2001-04-17
CO5261567A1 (es)	2003-03-31
DE59911879D1 (de)	2005-05-12
EA200100108A1 (ru)	2001-12-24
HUP0102913A2 (hu)	2002-01-28
EP1100509A1 (de)	2001-05-23
EE200100053A (et)	2002-06-17

Legal Events

Date	Code	Title	Description
2005-01-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20010468D0 (no)	2001-01-26	Anvendelse av biogene östrogensulfamater til hormonerstatningsterapi
DK0759280T3 (da)	1999-11-01	Skål til håndblanding
AU7109000A (en)	2001-03-26	Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes
DE60030720D1 (de)	2006-10-26	Intensivierungsmittel zur flüssigkeitsaufnahme
DE69623181D1 (de)	2002-10-02	Vorgepackter flüssiger Knochenzement
IL138129A0 (en)	2001-10-31	Therapy of estrogen associated disorders
DE69826451D1 (de)	2004-10-28	Anästehischer knochenzement
EP1143948A3 (en)	2002-09-11	Liver-selective glucocorticoid antagonist for treating diabetes
HUP0003428A3 (en)	2001-12-28	Use of leptin antagonists for the treatment of diabetes
HU9702039D0 (en)	1998-01-28	Estrogen agonist/antagonists treatment of atheroscerosis
AU7788500A (en)	2001-05-08	Use of substance p antagonists for influencing the circadian timing system
AU6909400A (en)	2001-03-13	Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction
DK1093361T3 (da)	2003-08-25	Steroidholdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf
ZA98484B (en)	1998-07-30	Use of beta3-adrenergic receptor agonists for the preparation of healing drugs
AU2440599A (en)	1999-09-15	Therapeutic agent for complication of diabetes
KR970053789U (ko)	1997-10-13	혼합시멘트공급용 사이로장치
TW377771U (en)	1999-12-21	Improvement for switch-controlling structure of faucet
GB9800784D0 (en)	1998-03-11	Medical plasters for all
AUPP162298A0 (en)	1998-02-26	Process for expression of thyroid stimulating hormone receptor
TW370976U (en)	1999-09-21	Improved structure of suspensory
SI1200158T1 (en)	2003-08-31	Mixture for the treatment of waste materials
HU9800046V0 (en)	1998-04-28	Structure for fracture of bone
TW504036U (en)	2002-09-21	Structure improvement of mouth-pipe for saxophone
TW457933U (en)	2001-10-01	Structure of extension device suitable for foot
TW360296U (en)	1999-06-01	Improvement for positioned structure of ground stopper